Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Interleukin-based therapy for Pulmonary Hypertension: IL-1β inhibits the development of pulmonary hypertension via down regulation of its target genes, 21/January/2015, 9.27 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that IL-1β, by increasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing  IL-1β or its activators”  may be used to treat pulmonary hypertension.

Amount: $ 500

Undisclosed information: How IL-1β inhibits the development of pulmonary hypertension

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Spread the love